Companies
Advancements in EGFR-Targeted Therapies: Promising Phase 1b Data for Firmonertinib in NSCLC Patients with Rare EGFR Mutations
Novel treatments show potential in addressing hard-to-treat mutations in lung cancer, bringing hope for improved outcomes ArriVent Biopharma recently unveiled...
Summit Therapeutics Announces Promising Phase III Trial Results for Ivonescimab in Lung Cancer
First-line treatment shows significant improvement in progression-free survival over pembrolizumab, marking a potential shift in NSCLC care Summit Therapeutics (SMMT)...
Mobileye Shifts Focus: Discontinues Internal FMCW Lidar Development for Autonomous Vehicles
Prioritizes Imaging Radar and Cost-Efficient Solutions for Eyes-Off Systems Mobileye (MBLY), a global leader in autonomous driving technology, has announced...
Super Micro Computer Stock Plunges Amid Annual Report Delay and Hindenburg Allegations, JP Morgan Downgrade
AI Leader Faces Intense Scrutiny as Analysts Downgrade Shares Super Micro Computer (SMCI), once hailed as one of the year’s...
Federal Judge Denies Coinbase’s Bid to Dismiss Shareholder Class Action
Shareholders Allege Fraud over Downplaying SEC Lawsuit Risks Coinbase (COIN), the largest cryptocurrency exchange in the U.S., faced a significant...
Broadcom’s Strong Q3 Results Fueled by AI and VMware Integration
Revenue Surges 47%, Adjusted EBITDA Reaches 63% of Revenue, and Dividend Declared Broadcom (AVGO), a global leader in semiconductor and...
C3.ai Beats Expectations Despite Accounting Shift: Strong AI Pipeline Driving Growth
FY1Q25 Results Showcase Revenue Beats and Expanding Partnerships Amid Adjustments in Revenue Reporting C3.ai (AI) delivered strong fiscal first-quarter 2025...
The Road to Electrification: White House Expands EV Charging Network Amidst Challenges
New Report Highlights Progress and Hurdles in the Push for a National Electric Vehicle Infrastructure The White House has released...
SYRE’s Innovative Biologics: A Game-Changer in Inflammatory Bowel Disease Treatment
Targeting Leading IBD Pathways, SYRE Aims to Redefine Efficacy and Convenience with Next-Generation Antibodies SYRE (SYRE), a clinical-stage biopharmaceutical company,...
Nordstrom’s Founding Family Makes $3.76 Billion Bid to Take Retailer Private
In Partnership with Mexico's Liverpool, Nordstrom Aims to Regain Control Amid Sales Challenges Nordstrom's (JWN) founding family has renewed its...
